“Maladaptive stress-coping behavior in CX3CR1-deficient mice: Impact of adolescent stress and alcohol exposure on neuroimmune responses and inflammation”
Dina Medina-Vera , Laura Martín-Chaves , Laura Sánchez-Marín , María Díaz-Ottaviano , Ana L. Gavito , Olga Popova , María José Sánchez-Quintero , Jorge Rodríguez-Capitán , Fernando Rodríguez de Fonseca , Manuel F. Jiménez-Navarro , Antonia Serrano , Francisco Javier Pavón-Morón
{"title":"“Maladaptive stress-coping behavior in CX3CR1-deficient mice: Impact of adolescent stress and alcohol exposure on neuroimmune responses and inflammation”","authors":"Dina Medina-Vera , Laura Martín-Chaves , Laura Sánchez-Marín , María Díaz-Ottaviano , Ana L. Gavito , Olga Popova , María José Sánchez-Quintero , Jorge Rodríguez-Capitán , Fernando Rodríguez de Fonseca , Manuel F. Jiménez-Navarro , Antonia Serrano , Francisco Javier Pavón-Morón","doi":"10.1016/j.neuropharm.2025.110503","DOIUrl":null,"url":null,"abstract":"<div><div>The CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 chemokine axis regulates synaptic pruning, plasticity, and stress-related behaviors, influencing resilience or vulnerability to psychiatric disorders. Adolescence, a critical period for neuroimmune development, increases susceptibility to stressors. This study investigated how adolescent restraint stress and alcohol exposure affect stress-coping behavior, neuroimmune signaling, and systemic inflammation in adult wild-type (WT) and CX<sub>3</sub>CR1 knock-out (KO) mice.</div><div>Eighty-one male and female WT and KO mice were assigned to control (non-stressed, saline-treated), stress (stressed, saline-treated), alcohol (non-stressed, alcohol-treated), and stress + alcohol (stressed, alcohol-treated) groups. Behavioral responses were evaluated using the tail suspension test. Hypothalamic gene expression of CX<sub>3</sub>CL1/CX<sub>3</sub>CR1, corticotropin-releasing hormone (CRH), and neuropeptide Y (NPY) systems was analyzed alongside plasma corticosterone, adrenocorticotropic hormone (ACTH), CX<sub>3</sub>CL1, and inflammatory mediators.</div><div>Adolescent stress—but not alcohol—increased plasma CX<sub>3</sub>CL1 levels, which inversely correlated with immobility time in WT mice. KO mice displayed higher baseline immobility than WT mice, whereas stress and/or alcohol paradoxically reduced immobility. These behavioral effects were reproduced by pharmacological inhibition of CX<sub>3</sub>CR1. Additionally, KO mice showed disrupted hypothalamic expression of multiple genes in the CRH pathway and <em>Npy1r</em>, attenuated corticosterone responses to stress, and abolished ACTH–corticosterone correlation, suggesting HPA axis dysregulation. KO mice also exhibited exacerbated inflammatory responses to stress and alcohol, including elevated IL-17A/F, IL-11, and IFN-β1 levels.</div><div>CX<sub>3</sub>CR1 deficiency disrupts neuroimmune homeostasis, leading to maladaptive stress-coping behaviors and heightened inflammatory reactivity. These findings underscore the protective role of the CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 axis in neuroinflammatory regulation and stress resilience, supporting CX<sub>3</sub>CR1 as a potential therapeutic target in stress-related disorders.</div></div>","PeriodicalId":19139,"journal":{"name":"Neuropharmacology","volume":"275 ","pages":"Article 110503"},"PeriodicalIF":4.6000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0028390825002096","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
The CX3CL1/CX3CR1 chemokine axis regulates synaptic pruning, plasticity, and stress-related behaviors, influencing resilience or vulnerability to psychiatric disorders. Adolescence, a critical period for neuroimmune development, increases susceptibility to stressors. This study investigated how adolescent restraint stress and alcohol exposure affect stress-coping behavior, neuroimmune signaling, and systemic inflammation in adult wild-type (WT) and CX3CR1 knock-out (KO) mice.
Eighty-one male and female WT and KO mice were assigned to control (non-stressed, saline-treated), stress (stressed, saline-treated), alcohol (non-stressed, alcohol-treated), and stress + alcohol (stressed, alcohol-treated) groups. Behavioral responses were evaluated using the tail suspension test. Hypothalamic gene expression of CX3CL1/CX3CR1, corticotropin-releasing hormone (CRH), and neuropeptide Y (NPY) systems was analyzed alongside plasma corticosterone, adrenocorticotropic hormone (ACTH), CX3CL1, and inflammatory mediators.
Adolescent stress—but not alcohol—increased plasma CX3CL1 levels, which inversely correlated with immobility time in WT mice. KO mice displayed higher baseline immobility than WT mice, whereas stress and/or alcohol paradoxically reduced immobility. These behavioral effects were reproduced by pharmacological inhibition of CX3CR1. Additionally, KO mice showed disrupted hypothalamic expression of multiple genes in the CRH pathway and Npy1r, attenuated corticosterone responses to stress, and abolished ACTH–corticosterone correlation, suggesting HPA axis dysregulation. KO mice also exhibited exacerbated inflammatory responses to stress and alcohol, including elevated IL-17A/F, IL-11, and IFN-β1 levels.
CX3CR1 deficiency disrupts neuroimmune homeostasis, leading to maladaptive stress-coping behaviors and heightened inflammatory reactivity. These findings underscore the protective role of the CX3CL1/CX3CR1 axis in neuroinflammatory regulation and stress resilience, supporting CX3CR1 as a potential therapeutic target in stress-related disorders.
期刊介绍:
Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).